Published in BMC Vet Res on January 05, 2017
Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1998) 7.05
Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol (2009) 3.19
Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg (2013) 2.65
Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants (1999) 2.47
Efficacy of autologous platelet-rich plasma use for orthopaedic indications: a meta-analysis. J Bone Joint Surg Am (2012) 2.31
IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med (2010) 2.15
Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg (2009) 1.90
The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials (2007) 1.77
Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors. Stem Cell Res Ther (2013) 1.56
Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives. Muscles Ligaments Tendons J (2014) 1.49
The use of autologous platelet-rich plasma in the orthopedic setting. Transfusion (2015) 1.46
TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev (2000) 1.40
Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF). Curr Pharm Biotechnol (2012) 1.27
Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage (2013) 1.22
Platelet rich therapies for long bone healing in adults. Cochrane Database Syst Rev (2012) 1.17
Reduced platelet concentration does not harm PRP effectiveness for ACL repair in a porcine in vivo model. J Orthop Res (2011) 1.16
Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R (2011) 1.15
Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel. BMC Vet Res (2013) 1.13
Evaluation of single and double centrifugation tube methods for concentrating equine platelets. Res Vet Sci (2006) 1.13
Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. Clin Chem (2002) 1.04
Comparison of hematologic values and transforming growth factor-beta and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood. Am J Vet Res (2004) 0.95
Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfus Med (2006) 0.95
Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses. Vet J (2013) 0.93
Release kinetics of VEGF165 from a collagen matrix and structural matrix changes in a circulation model. Head Face Med (2010) 0.92
Evaluation of the effects of platelet-rich plasma (PRP) therapy involved in the healing of sports-related soft tissue injuries. Iowa Orthop J (2012) 0.91
Equine autologous platelet concentrates: A comparative study between different available systems. Equine Vet J (2014) 0.85
A call for a standard classification system for future biologic research: the rationale for new PRP nomenclature. PM R (2015) 0.84
Activity of platelet-derived growth factor (PDGF) in platelet concentrates and cryopreserved platelets determined by PDGF bioassay. Vox Sang (1987) 0.79
Description of a double centrifugation tube method for concentrating canine platelets. BMC Vet Res (2013) 0.79
Effects of imidazoline and nonimidazoline alpha-adrenergic agents, including xylazine, medetomidine, yohimbine, tolazoline, and atipamezole, on aggregation of bovine and equine platelets. Am J Vet Res (2013) 0.78
Effects of xylazine, romifidine, or detomidine on hematology, biochemistry, and splenic thickness in healthy horses. Can Vet J (2014) 0.77
Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage. Cornea (2015) 0.77